Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.
Weiner
H L
HL
D000284:Administration, Oral; D000818:Animals; D000068717:Glatiramer Acetate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018448:Models, Immunological; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D007166:Immunosuppressive Agents; D010455:Peptides; D000068717:Glatiramer Acetate